产品名称 | NebuSelect™ Recombinant Human Galectin 1, hFc-tag |
---|---|
目录号 | NBL-241021 |
别名 | GAL1; Galectin-1; HLBP14; S-Lac lectin 1; LGALS1; GAL1; GBP; DKFZp686E23103 |
外观 | see COA |
分子量 | Ala2-Asp135 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P09382 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241021-100ug | 100ug | Inquire | Inquire | |
NBL-241021-1mg | 1mg | Inquire | Inquire | |
NBL-241021-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Galectin 1, hFc-tag
Catalog#:
NBL-241021
Description:
NebuSelect™ Recombinant Human Galectin 1, hFc-tag(Cat#NBL-241021) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Ala2-Asp135.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 41.9 kDa. Due to glycosylation, the protein migrates to 48-55 kDa based on Bis-Tris PAGE result.
Target Name:
GAL1; Galectin-1; HLBP14; S-Lac lectin 1; LGALS1; GAL1; GBP; DKFZp686E23103
Target Information:
Galectin 1(Gal-1), a β-galactoside binding mammalian lectin of 14KDa, is implicated in many signalling pathways, immune responses associated with cancer progression and immune disorders. Inhibition of human Gal-1 has been regarded as one of the potential therapeutic approaches for the treatment of cancer, as it plays a major role in tumour development and metastasis by modulating various biological functions viz. apoptosis, angiogenesis, migration, cell immune escape.
Amino Acid Sequence:
Ala2-Asp135
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.